Factor Eight Inhibitor Bypassing Activity (FEIBA) for Refractory Bleeding in Cardiac Surgery: Review of Clinical Outcomes
Balsam L, Timek T, Pelletier M. Factor Eight Inhibitor Bypassing Activity (FEIBA) for Refractory Bleeding in Cardiac Surgery: Review of Clinical Outcomes. Journal Of Cardiac Surgery 2008, 23: 614-621. PMID: 18793226, DOI: 10.1111/j.1540-8191.2008.00686.x.Peer-Reviewed Original ResearchConceptsChest tube outputBlood product utilizationPostoperative bleedingTube outputReview of clinical outcomesAdministration of blood productsAdministration of FEIBACardiac surgical proceduresInhibitor bypassing activityMultisystem organ failureCardiac surgery programFEIBA administrationRefractory bleedingCardiac surgerySurgical reexplorationRetrospective reviewRespiratory failureThrombotic eventsClinical outcomesMultiple dosesSingle doseFEIBAOrgan failureOperative reexplorationExtremity ischemia
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply